Pancreatic Cancer Screening: What To Expect

April 10, 2023
Precede Foundation

Did you know that 1 in 3 people will be diagnosed with cancer in their lifetime? And 1 in 64 people could be diagnosed with pancreatic cancer. As of now, surgery offers the best chance of treating pancreatic cancer. But, most patients are diagnosed at later stages and are not eligible for surgery. 

Unlike breast cancer and colon cancer, most people are not being screened for pancreatic cancer. That is why it is so important to know the symptoms, determine if you are at elevated risk, and keep up with annual medical checkups. Some common symptoms of pancreatic cancer include belly or back pain, weight loss and poor appetite, nausea and vomiting, and diabetes. Developing more readily available, non-invasive early detection tools and tests for pancreatic cancer are urgently needed. 

Who Needs Pancreatic Cancer Screening?

People who are at high risk of developing pancreatic cancer due to factors including family history, genetic mutations, or chronic pancreatitis are often advised to get screening tests. 

While screening and diagnostic tests for pancreatic cancer are available, many people are not part of an ongoing screening program even though they may be at higher risk than the general population.  While we do not know all the risk factors, the following are some that have already been identified:

  • High-risk individuals
    • Family History – People with a family history may have an increased risk of pancreatic cancer or Familial pancreatic cancer (FPC), if they have a first-degree relative (A parent, sibling, or child) who has the disease. Typically, about 10% of pancreatic cancers are considered familial or hereditary. Most cases of pancreatic cancer occur randomly or can be caused by factors such as smoking, obesity, and age.
    • Genetic Mutations – Certain genetic factors may increase the risk for pancreatic cancer, including: BRCA2, BRCA1 Mutation, and HNPCC (Hereditary Non-Polyposic Colorectal Cancer) Lynch Syndrome.
    • Chronic Pancreatitis – People with chronic inflammation of the pancreas are at increased risk of developing pancreatic cancer.
  • General population – People who are experiencing symptoms such as:
    • Unexplained weight loss
    • Digestive problems
    • Abdominal pain
    • Jaundice

What Is Involved In Pancreatic Cancer Screening?

Blood and imaging tests are frequently used for pancreatic cancer screening. Depending on a person’s medical history, symptoms, and risk factors, the individual screening test may change.

  • Imaging Tests
    • Endoscopic Ultrasound (EUS) – Involves passing a thin tube through the mouth into the stomach to create images of the pancreas and surrounding organs
    • Computed Tomography (CT) Scans  – Take a series of X-rays that create a 3D view of the pancreas and surrounding organs taken from different angles.
    • Magnetic Resonance Imaging (MRI) – It uses a strong magnetic field and radiofrequency waves. 
  • Blood Tests – The doctor may take blood samples to check:
    • Carbohydrate antigen 19-9 (CA19-9) – It is a tumor marker. Elevated levels of this may indicate cancer.
    • Carcinoembryonic antigen (CEA) – Another blood test that could be used to check for pancreatic cancer is the CEA test. Although elevated CEA levels, like the CA 19-9 test, can be a sign of cancer, they are not always accurate. It s not used as often as CA 19-9.

How To Donate To Cancer Research?

Access to early detection screening and genetic testing is crucial! TrovaNOW is raising funds for PRECEDE – an international, multi-institutional collaborative consortium of world-renowned experts in pancreatic cancer who are dedicated to increasing early detection and pancreatic cancer survival rates. 

If you have any questions or If you want more information about how to donate to cancer research, just email us at trovanow@gmail.com or learn more at http://trovanow.com

Knowing When To Ask For Help

There’s strength in recognizing when you need additional support. If you’re feeling consistently overwhelmed, anxious, or depressed, it may be time to speak with a healthcare professional. Warning signs can include ongoing sleep trouble, loss of appetite, or emotional numbness.

Mental health care is an important part of cancer recovery. There are therapists, social workers, and cancer-specific counselors trained to support your unique needs. Don’t hesitate to seek them out.

Your medical team can help adjust medications or recommend physical therapy if your symptoms are impacting your daily life. Being honest about your struggles allows your care providers to offer better, more personalized support.

The path to recovery from pancreatic cancer is rarely straightforward. It’s a mix of triumphs and setbacks, strength and vulnerability. But through each high and low, healing is happening. Be gentle with yourself. Allow space for rest, reflection, and growth.

You don’t have to go through this journey alone. With the right support, emotional, physical, and practical, you can move forward, one step at a time. And remember, every day you show up for yourself is a victory.

At TrovaNOW, we’re focused on finding a cure for pancreatic cancer. Every test and discovery brings us closer to better treatments and saving lives. Join us and learn more at TrovaNOW.

Visual related to world cancer day: a call to action against pancreatic cancer

World Cancer Day: A Call to Action Against Pancreatic Cancer

Learn more about world cancer day: a call to action...
Visual related to what to know about the whipple procedure

What To Know About The Whipple Procedure

Learn more about what to know about the whipple procedure...
Visual related to setting recovery-focused new year’s resolutions

Setting Recovery-Focused New Year’s Resolutions

Learn more about setting recovery-focused new year’s resolutions and how...

Inaugural Gala

October 28, 2025 | 6pm-10pm | Tribeca Rooftop

Your donation directly supports this groundbreaking work, including the infrastructure, scientific collaborations, and patient-focused efforts that are accelerating early detection tools with the potential to raise survival rates from 13% to 50%.